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Summary:
Weightless conditions of space flight accelerate bone loss.  There are no reports to date 
that address whether the bone that is lost during spaceflight could ever be recovered.   Space-
induced bone loss in astronauts is evaluated at the Johnson Space Center (JSC) by measurement of 
bone mineral density (BMD) by Dual-energy x-ray absorptiometry (DXA) scans.  Astronauts are 
routinely scanned preflight and at various time points postflight (>Return+2 days).  Two sets of 
BMD data were used to model spaceflight-induced loss and skeletal recovery in crewmembers 
following long-duration spaceflight missions (4-6 months).   Group I was from astronauts (n=7) 
who were systematically scanned at multiple time points during the postflight period as part of a 
research protocol to investigate skeletal recovery.  Group II came from a total of 49 sets of 
preflight and postflight data obtained by different protocols.  These data were from 39 different 
crewmembers some of whom served on multiple flights.  
Changes in BMD (between pre- and postflight BMD) were plotted as a function of time 
(days-after-landing); plotted data were fitted to an exponential equation which enabled estimations 
of i) BMD change at day 0 after landing and ii) the number of days by which 50% of the lost bone 
is recovered (“half-life”).  These fits were performed for BMD of the lumbar spine, trochanter, 
pelvis, femoral neck and calcaneus.  
There was consistency between the models for BMD recovery.  Based upon the 
exponential model of BMD restoration, recovery following long-duration missions appears to be 
substantially complete in crewmembers within 36 months following return to Earth. 
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Introduction
The acceleration of bone loss in crewmembers on spaceflight missions is a well-recognized 
effect of weightlessness on the skeletal system and is formally identified as a high critical risk 
factor in the NASA Bioastronautics Roadmap.1 Identifying how weightlessness affects bone cell 
biology and skeletal physiology is critical to the development and evaluation of countermeasures to 
be used for long-duration space missions.
Due to the difficulty of obtaining bone-related measurements during flight, characterization 
of spaceflight-induced osteopenia has been limited largely to pre- and postflight measurements.  
Site-specific deficits in bone mineral density (BMD),2, 3 increased excretion of collagen degradation 
products,4, 5 disrupted bone turnover,6, 7 and negative calcium balances4 all suggest a net loss of 
bone mineral as an adaptive response of the skeleton to the unloading during spaceflight.  
Assays of bone biomarkers suggest that bone formation is uncoupled from bone resorption 
as the adult skeleton adapts to the weightless environment of space.  The JSC Biochemistry 
Nutrition Lab detected increased levels of the cross-linked amino-terminal collagen telopeptide 
(NTX) in urine specimens collected from crewmembers in flight.  The levels of this collagen 
degradation product were reduced back to preflight levels at the time of landing and remained at 
this level throughout various time-points in the postflight period.4  Similarly, serum markers for 
bone formation, i.e., osteocalcin and bone-specific alkaline-phosphatase, were assayed in 
specimens obtained before, during and after flight.     Assays indicate that there was no impact of 
spaceflight on either of these markers but a significant increase in both of these markers was 
detected after one month following return to earth.4  These data suggest that there was delayed 
stimulation of bone formation after return to earth’s gravity.  Interestingly, these results 
corroborate the increase in bone formation markers observed in subjects in a bed rest study – the 
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gold standard for ground-based space analogs -- during the re-ambulation phase of the experiment.8  
Currently, measurements of bone biomarkers are conducted in long-duration crewmembers and are 
scheduled to coincide with measurements of BMD.
While there are studies that characterize bone health during spaceflight through calcium 
kinetics and bone biomarkers, there are no reports that address the impact of spaceflight on bone 
health after spaceflight, i.e., is there skeletal recovery upon return to earth?
Measurement of bone mineral mass and density has been a long-standing technique to 
evaluate spaceflight effects on the skeleton.   Because of the rapid bone loss reported in spaceflight, 
densitometry has been capable of detecting site-specific deficits in bone mineral in a crewmember 
that flew on a mission as short as 2 months.3   Furthermore, as a technique to evaluate changes in 
mineral metabolism, pre- and postflight densitometry scans are more easily accommodated by 
crewmembers when compared to the invasiveness of bone biopsy or the constraints of urine and 
blood specimen collections.  
It is part of the medical requirements for health assessment of the Astronaut Corps that 
BMD be measured to monitor skeletal integrity. As per the Astronaut Medical Evaluation 
Requirements Document (AMERD), the Bone and Mineral Lab at NASA JSC routinely performs 
measurements of BMD in crewmembers by Dual-energy X-ray Absorptiometry (DXA).    DXA 
scans are performed to ensure that crewmembers i) meet the medical standards for flight 
certification  and ii) are restored to preflight skeletal status.  In addition to being able to delineate 
site-specific losses of the adult skeleton to spaceflight, these DXA scans enable an analysis of 
skeletal recovery in crewmembers, especially in those who return after long-duration spaceflights, 
i.e., 4-6 months.  
Additionally, the accumulation of densitometry data provides an important research 
database to the space program.  The cross-sectional measurements could be analyzed to evaluate 
Bone Loss during Spaceflight   
5
the efficacy of in-flight countermeasures or the impact of flight duration (or of previous flights) on 
skeletal recovery.  Assessment of risk factors, as well as the contribution of genomics, could 
elucidate crew-specific variations in bone loss.  Moreover, bone densitometry has had widespread 
use in the clinical arena which provides an extensive reference database from which to draw 
comparisons of “spaceflight osteoporosis” to postmenopausal or age-related osteoporosis.  BMD is 
also the primary index by which the efficacy of in-flight countermeasures, such as exercise 10, 11 or 
pharmacologics 11, 12 are evaluated in ground-based models for spaceflight 
The JSC Bone and Mineral Lab analyzed postflight BMD data to model the skeletal 
recovery of astronauts who returned from long-duration spaceflight.  JSC also had access to 
densitometry data (pre- and postflight scans) of Russian cosmonauts who similarly served on long-
duration missions.  BMD data were analyzed i)  to determine whether the crewmembers were able 
to recover their skeletal deficits upon return to life on earth  and ii) to understand the rate of 
skeletal recovery following prolonged space occupation(between 4-6 months).  
Data Source.  The data described herein are a subset of medical data archived by the 
Office for the Longitudinal Study of Astronaut Health at NASA JSC.  Authorization to publish 
these data was obtained from the office overseeing this study in addition to IRB approval from the 
JSC Committee for Protection of Human Subjects.
DXA scans of crewmembers were conducted on either the Hologic 1000w, 2000 or QDR 
4500 models..   Scans of astronauts were performed preflight, within 45-30 days before launch, 
and postflight at various intervals during the first 3 years after landing.  Postflight scans were 
scheduled for 5 times during this period unless the crewmember is within 2% of preflight BMD, in 
which case only one other BMD measurement for confirmation is required.  A series of six scans 
were performed for each scan date.  Scans included whole body, lumbar spine, hip and the 
calcaneus.   BMD data for the pelvis were obtained from the whole body scan, while scans of hip 
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yielded data for trochanter and femoral neck of the proximal femur. 
BMD data came from a combination of 45 crewmembers who served on the ISS and the Mir 
spacecraft.   These BMD data were separated into two datasets.   Dataset I was obtained from 
seven NASA astronauts (Group I) who flew on the Russian spacecraft Mir between 1995 and 
1998.  As part of a research study of skeletal recovery, these Mir Astronauts were scanned at 
specific time points following landing  (5 days, 6 months, 12 months, 24 months and 36 months 
after return) --  a protocol that was later adopted by the AMERD to monitor the return of BMD to 
preflight status.  Dataset II was obtained from a total of 39 different crewmembers (Group II) who 
served on 49 separate missions because of multiple flights by some crewmembers.  Crewmembers 
consisted of 12 astronauts who flew on the International Space Station (ISS) (2000- 2004), as well 
as 22 cosmonauts who flew on Mir (1990-1998) and 5 cosmonauts who flew ISS  (1990-2004).    
Datasets for the cosmonauts were not as extensive as those for the astronauts; a typical cosmonaut 
dataset consisted of one preflight scan and one immediate postflight scan.   Because the data were 
obtained under different protocols, analysis of Dataset I was performed separately from the 
analysis of Dataset II .
Mathematical Model for Skeletal Recovery  The difference in preflight and postflight 
BMD was used as an index of bone changes as a consequence of spaceflight.  In cases of multiple 
preflight BMDs, deficits were calculated from the scan closest to the date of launch.  Multiple 
missions by a single crewmember were treated as independent observations of spaceflight-induced 
bone loss and recovery.  
The deficits from preflight BMD were calculated for each postflight scan that was 
conducted on a crewmember and expressed as a percentage of preflight bone density.  Percentages 
were plotted as a function of time, i.e., against Days-after-Landing. Initial review of the plotted 
data suggested an exponential relationship between the increase in BMD and the increased time 
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after landing.  Thus, the data were fitted to a 2-parameter exponential mathematical equation:   Lt 
=  L0 *exp[ ln(0.5)*t/HL] where Lt is the change in BMD detected at time “t” after landing, L0 is 
the change in BMD that could be estimated for the time of landing (“R+0”) and HL denotes the 
time at which there is a 50% restoration of the bone lost during spaceflight.  
This mathematical fit generated a model that could relate the loss of BMD induced by 
spaceflight (L0) and the temporal recovery of BMD to preflight status (HL). This mathematical 
model -- analogous to the decay of a radioisotope – uses the “half-life” term (HL) as a metric to 
assess how quickly the skeleton recovers.  Half-life -- hereto in referred to as “50% Recovery 
Time” -- was calculated for the five skeletal sites of interest (i.e., lumbar spine, pelvis, femoral 
neck, trochanter and calcaneus).    
As mentioned previously, there were two datasets representing different numbers of 
crewmembers (n=7 vs. 39) and obtained under different levels of stringency. The research data of 
Group I were more systematically obtained but limited by a small number of individuals; the data 
from Group II conversely benefited from the large number of individuals but were not obtained 
with as much scientific rigor.  In addition, there were 49 sets of preflight and postflight scans in 
Dataset II available from the 39 crewmembers (Group II).    The apparent “inconsistency” stems 
from nine crewmembers that flew on multiple missions with two of those same crewmembers flying 
on  three missions.  Each BMD set from a man-mission was treated as an independent observation 
even though the crewmember may have flown on a previous long-duration space mission.  Finally, 
one male astronaut in Group II previously flew on a Mir mission (Group I).   Because of the 
variability between datasets, each dataset was fitted separately to the mathematical model and the 
two models were evaluated for consistency between the respective estimations of bone loss and 
recovery times per skeletal site.
Analysis  The presence of repeated measures of a single crewmember would not allow a 
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direct comparison of model averages.  The consistency between the two models for bone loss, 
however, could be evaluated by a Monte Carlo Simulation.  In brief, a random sampling of the 
respective datasets was performed and fitted to the exponential recovery model.  This “simulation” 
was performed 10,000 times and a distribution of error for the most probable estimation for bone 
loss was obtained.    The error distributions were compared to evaluate consistency between the 
spaceflight-induced bone losses as simulated by both groups of data (Group I vs. Group II).  
Likewise, the error distributions for the 50 % Recovery Times were compared to evaluate the 
consistency between skeletal site-specific recovery times and between the two datasets.  
Results
The average age of all the crewmembers was 43.2+5.2 years (Group I: 42.8+0.7; Group 
II” 45.9+2.3).    The average flight duration was 173+24 d (range126-208 d); the average flight 
duration was 181+47 days with the inclusion of the two crewmembers that flew on prolonged 
missions of 311 and 438 days.   Data were obtained from 42 male crewmembers and 3 female 
crewmembers (Group I:   6 males:1 female; Group II:37 males:2 females)  
The bone loss estimated from the fit of Dataset I was consistent with the loss estimated 
from the fitted Dataset II with a few exceptions With its smaller number of crewmembers, Dataset 
I estimated that the least amount of bone loss occurred in both the calcaneus and the lumbar spine   
In contrast, Dataset II suggested that the calcaneus was a site that lost the least amount of BMD 
compared to the other sites.  . Additionally, Dataset I estimated a significantly greater bone loss in 
the trochanter than the loss predicted by Dataset II.
Due to the large distributions of error, there was no indication that one dataset provided an 
advantage over the other in the prediction of skeletal recovery or that one skeletal site had a shorter 
recovery time over another site.  
There were limitations to this evaluation of skeletal recovery.   The impact of multiple long-
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duration missions or of spaceflight duration on crewmember recovery could not be evaluated due to 
insufficient power in the analysis.  These data were also a mixture of cross-sectional and 
longitudinal measurements which required simulation analysis in order to take full advantage of the 
limited number of data-points.  More importantly, skeletal recovery is a crew-specific phenomenon 
influenced by nutrition, exercise re-conditioning, neurosensory re-adaptation and a likely genomic 
component.13   There were some crewmembers who recovered within the first year of return.
However, if skeletal recovery were modeled by the data from the largest number of 
crewmembers (i.e., Group II) and the 95% confidence limits were not taken into account, then a 
fair estimation of skeletal recovery could be “within” 3 years of return to earth.  This prediction is 
based upon the estimated recovery in the trochanter which has the longest 50% Recovery half-life. 
With 50% recovery at around 9 months for the trochanter, a restoration of 15/16ths, or 94% of lost 
bone would occur four half-lives later (i.e., 36 months). 
Based upon this estimation, most crewmembers that have flown on long-duration missions 
(4-6 months) could be re-certified for flight within 3 years – suggesting that recovery is 
approximately 6x mission durations.  Bone biomarkers suggest that the uncoupled bone formation 
is not stimulated immediately upon return to unit gravity.4 This delayed recovery is not unexpected 
when one considers that its takes relatively less time to lose bone (weeks) than it does to produce 
and mineralize matrix (months).14   The observed increase in bone formation markers, after the 
normalization of bone resorption markers, is not only corroborated by bed rest studies8 but 
predictive for the BMD response.
Nevertheless, there are issues that remain unresolved.  For example, the kinetics of bone 
loss during spaceflight will not be fully characterized until technologies to assess bone mass in 
flight are validated and manifested for in-flight implementation. Furthermore, it is recognized that 
BMD is not the sole determinant of bone strength:  BMD, rather, needs to be supplemented by 
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indices that more appropriately reflect “bone quality.”  Measurements of microarchitecture in 
cancellous bone, assessments of bone size and geometry, evaluations of anisotropy and trabeculae 
distribution are a few of the parameters considered reflective of bone quality.  In vivo assessments 
are emerging that could allow non-invasive measurements of these indices.  In the meantime, the 
recovery of BMD after spaceflight should not be perceived as a restoration of mechanical strength 
until these additional indices can be evaluated in crewmembers.  Only then can bone health after 
spaceflight be fully evaluated.
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